Riskpilot← Back to searchSign inGet full accessTRAITOMIC A/S
A/SActiveCVR 43713523J.C. Jacobsens Gade 1Research and experimental development on natural sciences and engineering · NACE 7210Est. 202230 employees
Revenue 2024
DKK 18M
-22% vs 2023
EBITDA margin
-182.3%
-68% vs 2023
Equity ratio
79.0%
Financial strength
Net profit 2024
DKK -26,9M
-33% vs 2023
| Revenue | DKK 18M | -22% |
| EBITDA | DKK -32,9M | -68% |
| Net profit | DKK -26,9M | -33% |
| Total assets | DKK 234,5M | -3% |
| Equity | DKK 185,2M | -13% |
| Employees | 30 | — |
Legal name
TRAITOMIC A/S
CVR number
43713523
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
16. december 2022
Share capital
DKK 400.000
Employees
30 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af ét medlem af bestyrelsen i forening med én direktør, eller af to
medlemmer af bestyrelsen i forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive kommercielle aktiviteter inden for biotek, herunder udvikling af mikrober eller planter gennem en patenteret udviklingsteknologi samt enhver dertil knyttet aktivitet.
Address
J.C. Jacobsens Gade 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 0 | 23.202 | 18.027 |
| Staff expenses | -0 | -0 | -0 |
| EBITDA | 0 | -19.536 | -32.864 |
| Depreciation & amort. | -0 | -0 | -0 |
| EBIT | 0 | -19.536 | -32.864 |
| Net financials | -368 | -6.669 | -1.912 |
| Profit before tax | -368 | -26.205 | -34.776 |
| Tax | -81 | -5.974 | -7.859 |
| Net profit | -287 | -20.231 | -26.917 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 225.964 | 241.408 | 234.472 |
| Equity | 113 | 212.271 | 185.150 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 225.851 | 29.137 | 49.292 |
| Total debt | 225.851 | 29.137 | 49.292 |
EBITDA margin
-182.3%
This company
15.8%
Market median
-1254% vs market
20222024
Equity ratio
79.0%
This company
38.2%
Market median
+107% vs market
20222024
Return on equity
-14.5%
This company
18.4%
Market median
-179% vs market
20222024
Net profit margin
-149.3%
This company
8.1%
Market median
-1943% vs market
20222024
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
20222024
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
20222024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-12-16 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
GG Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Chairman | 2022 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
CARLSBERG BREWERIES A/S | Company | 100.0% | 100.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CARLSBERG A/S
TRAITOMIC A/S Board members of TRAITOMIC A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gustav Göran Hambraeus | Chief Executive Officer | 0 companies |
| Gábor Zeisler | Board of Directors | 0 companies |
| Søren Brinck | Chairman | 0 companies |
| Anders Røed | Chairman | 0 companies |
| Carsten Sparre Conrad | Board of Directors | 0 companies |
| Mads Krab | Board of Directors | 0 companies |
| Hanne Vibeke Weywardt | Board of Directors | 0 companies |